PLIVA 459 (Theophylline extended-release 300 mg)

This pill with imprint "PLIVA 459" is White, Capsule-shape and has been identified as Theophylline extended-release 300 mg. It is manufactured by Pliva Inc..

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Theophylline extended-release

Imprint:

PLIVA 459

Strength:

300 mg

Color:

White

Size:

14.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Methylxanthines

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Pliva Inc.

National Drug Code (NDC):

50111-0459

Inactive Ingredients:

hypromellose 2208 (100 mPa.s)
hypromellose 2208 (100000 mPa.s)
lactose anhydrous
magnesium stearate
povidone

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.